TP53 and cancer: Considering the tremendous complexity of the TP53 mutome with its rainbow of more than 2000 functionally diverse mutants, it will certainly remain a challenging task to pinpoint p53-dependent changes in EV secretion that are clinically relevant and characteristic for a larger number of p53 mutants across a broad range of cancer entities.